Lung Cancer Considered

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information. Lung Cancer considered is funded in part by Current sponsors: • AbbVie • AstraZeneca • Gilead • J&J • Summit

Tämä podcast on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi podcastin jaksot saattavat sisältää mainontaa.

Jaksot(391)

"I'm in Barcelona, Now What?" — Tips for First-Time WCLC Attendees

In this episode of Lung Cancer Considered, Dr. Narjust Florez and Dr. Stephen Liu share tips for first-time attendees of the World Conference on Lung Cancer (WCLC). Recorded live at WCLC 2025, hear th...

6 Syys 202519min

LCC in Mandarin: Neoadjuvant and Perioperative Therapy for Locally Advanced NSCLC

LCC in Mandarin: Neoadjuvant and Perioperative Therapy for Locally Advanced NSCLC by IASLC

29 Elo 202552min

IASLC - ALK Positive Summit

IASLC - ALK Positive Summit by IASLC

26 Elo 202538min

LCC in Greek: Virtual Tumor Board - ALK NSCLC

LCC in Greek: Virtual Tumor Board - ALK NSCLC by IASLC

22 Elo 20251h

Lung Cancer Considered--STK11 and KEAP1 as resistance mechanisms to immunotherapy

Lung Cancer Considered--STK11 and KEAP1 as resistance mechanisms to immunotherapy by IASLC

19 Elo 202553min

LCC in Cantonese: Novel Treatment for Advanced EGFR Mutant Lung Cancer

LCC in Cantonese: Novel Treatment for Advanced EGFR Mutant Lung Cancer by IASLC

15 Elo 20251h 4min

FDA Approval: Zongertinib for HER2 Mutant NSCLC

FDA Approval: Zongertinib for HER2 Mutant NSCLC by IASLC

12 Elo 202541min

LCC in Arabic: Arab Women's Voices in Thoracic Oncology

As part of IASLC’s ongoing series of podcasts in world languages, Dr. Nagla Abdel Karim moderates a discussion in Arabic with Dr. Asrar AlAhmadi and Dr. Maya Khalil. The group discusses the journey an...

8 Elo 202533min